Patents by Inventor Joseph Terracciano

Joseph Terracciano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140303136
    Abstract: This disclosure provides pharmaceutical compositions comprising ceftolozane, pharmaceutical compositions comprising ceftolozane and tazobactam, methods of preparing those compositions, and related methods and uses of these compositions.
    Type: Application
    Filed: April 11, 2014
    Publication date: October 9, 2014
    Inventors: Joseph Terracciano, Nicole Miller Damour, Yanmei Lan, Jonathan Cam Ly, Jianxun Zhou
  • Publication number: 20140274998
    Abstract: Pharmaceutical compositions can include ceftolozane lyophilized in the absence of tazobactam.
    Type: Application
    Filed: May 22, 2014
    Publication date: September 18, 2014
    Applicant: Cubist Pharmaceuticals, Inc.
    Inventors: Joseph Terracciano, Nicole Miller Damour
  • Publication number: 20140274995
    Abstract: Parenteral pharmaceutical compositions including ceftolozane and tazobactam can be formulated to provide desired levels of osmolality, pH and ceftolozane stability.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Inventors: Jianxun Zhou, Nicole Miller Damour, John Fred Mohr, Joseph Terracciano, Jacqueline Marie Walsh
  • Publication number: 20140274991
    Abstract: Pharmaceutical compositions can include ceftolozane and an amount of sodium chloride effective to provide improved ceftolozane stability.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Inventors: Nicole Miller Damour, Joseph Terracciano
  • Publication number: 20140274992
    Abstract: Pharmaceutical formulations can include ceftolozane and an alkalizing agent such as L-arginine.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Inventors: Nicole Miller Damour, Jacqueline Marie Walsh, Joseph Terracciano
  • Publication number: 20140274993
    Abstract: Pharmaceutical compositions can include ceftolozane lyophilized in the absence of tazobactam.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Inventors: Joseph Terracciano, Nicole Miller Damour
  • Publication number: 20140275000
    Abstract: Pharmaceutical compositions can include an amount of sodium chloride effective to stabilize ceftolozane in an antibiotic formulation.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Inventors: Nicole Miller Damour, Joseph Terracciano
  • Publication number: 20140274996
    Abstract: This disclosure provides pharmaceutical compositions comprising ceftolozane, pharmaceutical compositions comprising ceftolozane and tazobactam, methods of making those compositions, and related methods and uses of these compositions.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Inventors: Nicole Miller Damour, Joseph Terracciano
  • Publication number: 20140274990
    Abstract: Pharmaceutical compositions can include an amount of sodium chloride effective to stabilize ceftolozane in a lyophilized formulation.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Inventors: Joseph Terracciano, Nicole Miller Damour
  • Publication number: 20140274989
    Abstract: This disclosure relates to the manufacture of pharmaceutical compositions comprising an antibiotic compound and a beta-lactamase inhibitor compound when both compounds have a chemical structure that includes a beta-lactam ring, as well as resulting pharmaceutical compositions.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Inventors: Joseph Terracciano, Nicole Miller Damour
  • Publication number: 20140274997
    Abstract: Pharmaceutical compositions including a cephalosporin disclosed herein as having the structure of formula (III).
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Inventors: Jianxun Zhou, Nicole Miller Damour, Yanmei Lan, Jonathan Cam Ly, Joseph Terracciano
  • Publication number: 20140262868
    Abstract: Pharmaceutical compositions are provided in unit dosage forms comprising ceftolozane and tazobactam in separate unit dosage form containers, ceftolozane prepared in the absence of tazobactam, tazobactam prepared in the absence of ceftolozane, and/or compositions where ceftolozane and tazobactam are first combined within a unit dosage form container.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Inventors: Joseph Terracciano, Nicole Miller Damour
  • Publication number: 20140228337
    Abstract: This disclosure provides compositions containing solid forms of tazobactam arginine, and methods of manufacturing and using these compositions.
    Type: Application
    Filed: February 14, 2014
    Publication date: August 14, 2014
    Applicant: CUBIST PHARMACEUTICALS, INC.
    Inventors: Jan-Ji Lai, Jian-Qiao Gu, Pradip M. Pathare, Valdas Jurkauskas, Joseph Terracciano, Nicole Miller Damour
  • Publication number: 20140213567
    Abstract: This disclosure provides compositions comprising a beta-lactam compound and crystalline tazobactam arginine, and related methods and uses of these compositions.
    Type: Application
    Filed: March 28, 2014
    Publication date: July 31, 2014
    Inventors: Jan-Ji Lai, Jian-Qiao Gu, Pradip M. Pathare, Valdas Jurkauskas, Joseph Terracciano, Nicole Miller Damour
  • Publication number: 20140206659
    Abstract: This disclosure provides compositions comprising a beta-lactam compound and crystalline tazobactam arginine, and related methods and uses of these compositions.
    Type: Application
    Filed: April 11, 2014
    Publication date: July 24, 2014
    Inventors: Jan-Ji Lai, Jian-Qiao Gu, Pradip M. Pathare, Valdas Jurkauskas, Joseph Terracciano, Nicole Miller Damour
  • Publication number: 20140187528
    Abstract: This disclosure provides compositions comprising a beta-lactam compound and crystalline tazobactam arginine, and related methods and uses of these compositions.
    Type: Application
    Filed: March 7, 2014
    Publication date: July 3, 2014
    Inventors: Jan-Ji Lai, Jian-Qiao Gu, Pradip M. Pathare, Valdas Jurkauskas, Joseph Terracciano, Nicole Miller Damour
  • Patent number: 8685957
    Abstract: This disclosure provides compositions containing solid forms of tazobactam arginine, and methods of manufacturing and using these compositions.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: April 1, 2014
    Assignee: Cubist Pharmaceuticals, Inc.
    Inventors: Jan-Ji Lai, Jian-Qiao Gu, Pradip M. Pathare, Valdas Jurkauskas, Joseph Terracciano, Nicole Miller Damour
  • Publication number: 20140088067
    Abstract: This disclosure provides compositions containing solid forms of tazobactam arginine, and methods of manufacturing and using these compositions.
    Type: Application
    Filed: March 14, 2013
    Publication date: March 27, 2014
    Applicant: Cubist Pharmaceuticals, Inc.
    Inventors: Jan-Ji Lai, Jian-Qiao Gu, Pradip M. Pathare, Valdas Jurkauskas, Joseph Terracciano, Nicole Miller Damour
  • Patent number: 8476425
    Abstract: This disclosure provides compositions containing solid forms of tazobactam arginine, and methods of manufacturing and using these compositions.
    Type: Grant
    Filed: September 27, 2012
    Date of Patent: July 2, 2013
    Assignee: Cubist Pharmaceuticals, Inc.
    Inventors: Jan-Ji Lai, Jian-Qiao Gu, Pradip M. Pathare, Valdas Jurkauskas, Joseph Terracciano, Nicole Miller Damour
  • Patent number: 6476062
    Abstract: Novel tetramic acid-type compounds isolated from a CCR-5 active complex produced by fermentation under controlled conditions of a biologically pure culture of the microorganism, Chaetomium globosum Kunze SCH 1705, ATCC 74489., pharmaceutical compositions containing the compounds and the use of the CCR-5 antagonist compounds and compositions to treat HIV-1 infections in humans are disclosed.
    Type: Grant
    Filed: March 23, 2001
    Date of Patent: November 5, 2002
    Assignee: Schering Corporation
    Inventors: Min Chu, Ronald A. Mierzwa, Joseph Terracciano, Mahesh G. Patel